遗传性球形红细胞增多症的嗜酸性粒细胞5'-马来酰亚胺（EMA）结合试验的参考范围和临界值在每个年龄组中是否具有特异性？ - Suppr | 超能文献

Are the Reference Ranges and Cutoff Values of Eosin-5'-Maleimide (EMA) Binding Test for Hereditary Spherocytosis Specific for Each Age Group?

作者信息

Falay Mesude, Ulusan Gul E, Şenes Mehmet, Acar Ismail O

出版信息

Clin Lab. 2018 Jun 1;64(6):1101-1103. doi: 10.7754/Clin.Lab.2018.180124.

DOI:10.7754/Clin.Lab.2018.180124

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Are the Reference Ranges and Cutoff Values of Eosin-5'-Maleimide (EMA) Binding Test for Hereditary Spherocytosis Specific for Each Age Group?遗传性球形红细胞增多症的嗜酸性粒细胞5'-马来酰亚胺（EMA）结合试验的参考范围和临界值在每个年龄组中是否具有特异性？

Clin Lab. 2018 Jun 1;64(6):1101-1103. doi: 10.7754/Clin.Lab.2018.180124.

2

Eosin-5'-maleimide binding test-Do we use appropriate reference values to detect hereditary spherocytosis in neonates?嗜酸性粒细胞-5'-马来酰亚胺结合试验——我们是否使用适当的参考值来检测新生儿遗传性球形红细胞增多症？

Int J Lab Hematol. 2019 Jun;41(3):e57-e60. doi: 10.1111/ijlh.12958. Epub 2018 Dec 10.

3

Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.遗传性球形红细胞增多症中伊红 5'-马来酰亚胺结合试验、流式细胞术渗透脆性试验和冷冻溶血试验的对比研究。

Am J Clin Pathol. 2014 Oct;142(4):474-84. doi: 10.1309/AJCPO7V4OGXLIIPP.

4

Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.采用嗜酸性-5'-马来酰亚胺结合试验诊断遗传性球形红细胞增多症。

Pediatr Int. 2014 Jun;56(3):427-9. doi: 10.1111/ped.12293.

5

Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.通过结合光学显微镜检查、酸化甘油溶解试验和嗜酸性-5'-马来酰亚胺结合试验对遗传性球形红细胞增多症进行产后早期诊断。

Ann Hematol. 2015 Dec;94(12):1959-64. doi: 10.1007/s00277-015-2491-z. Epub 2015 Sep 4.

6

Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.嗜酸性粒细胞-5-马来酰亚胺与带3蛋白和Rh相关蛋白的结合构成了遗传性球形红细胞增多症筛查试验的基础。

Br J Haematol. 2004 Jan;124(1):106-13. doi: 10.1046/j.1365-2141.2003.04730.x.

7

Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.运用嗜酸性-5-马来酰亚胺结合试验进行遗传性球形红细胞增多症和遗传性热异形红细胞增多症的鉴别诊断。

Cytometry B Clin Cytom. 2008 Jul;74(4):244-50. doi: 10.1002/cyto.b.20413.

8

Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.迈向遗传性球形红细胞增多症诊断中嗜酸性粒细胞5'-马来酰亚胺结合试验结果呈现的标准化。

Cytometry B Clin Cytom. 2015 Jan;88(1):50-7. doi: 10.1002/cyto.b.21187. Epub 2014 Sep 16.

9

Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.流式细胞术渗透脆性试验和伊红 5'-马来酰亚胺染料结合试验比传统渗透脆性试验更有助于遗传性球形红细胞增多症的诊断。

Int J Lab Hematol. 2018 Jun;40(3):335-342. doi: 10.1111/ijlh.12794. Epub 2018 Mar 24.

10

Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins.通过曙红 5-马来酰亚胺（EMA）结合试验检测遗传性热不稳定血影蛋白溶血病归因于 EMA 反应性跨膜蛋白的显著减少。

Int J Lab Hematol. 2011 Apr;33(2):205-11. doi: 10.1111/j.1751-553X.2010.01270.x. Epub 2010 Nov 3.

引用本文的文献

1

Facilitating EMA binding test performance using fluorescent beads combined with next-generation sequencing.使用荧光珠结合下一代测序技术促进欧洲药品管理局（EMA）结合试验性能

EJHaem. 2021 Sep 9;2(4):716-728. doi: 10.1002/jha2.277. eCollection 2021 Nov.

2

Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry.采用流式细胞术通过嗜酸性-5-马来酰亚胺（EMA）染色检测骨髓增生异常综合征中的红细胞膜蛋白

Hematol Rep. 2022 Feb 28;14(1):13-18. doi: 10.3390/hematolrep14010003.

3

Improving the EMA Binding Test by Using Commercially Available Fluorescent Beads.使用市售荧光微球改进欧洲药品管理局结合试验

Front Physiol. 2020 Sep 15;11:569289. doi: 10.3389/fphys.2020.569289. eCollection 2020.